Literature DB >> 14670539

Correlation between p53 mutations and HPV in bilharzial bladder cancer.

Hussein M Khaled1, Abeer A Bahnassi, Abdel-Rahman N Zekri, Hatem Aboul Kassem, Nadia Mokhtar.   

Abstract

Alterations of the p53 tumor suppressor gene are the most common genetic changes detected in human cancers as well as in papillary and invasive bladder cancer. Several studies have demonstrated an association between HPV infection and urological malignancies. In the present work, the p53 gene status was studied together with the frequency of HPV in 99 cases of Bilharzial bladder cancer [BBC] in Egypt and both were correlated to the clinicopathological features of the patients. SSCP and sequencing were used to screen the p53 gene for mutations at exons 4-10 and IHC was performed to detect protein overexpression. PCR was used for detection and typing of HPV-DNA in tumor samples. p53 mutations were detected in 33.3% of the studied cases whereas protein overexpression was detected in 35.6% of the cases. The highest concordance rate was observed in cases harboring mutations at exon 4 [87.5%]. Bilharzial infestation was obvious in 72.2% of the cases that showed mutations. Exon 8 showed the highest rate of mutation [32%] followed by exons 4 and 5 [22% each]. The commonest mutational event was G:C transversion [15/50] especially at CpG dinucleotides. A mutational hot spot was detected at exon 4, codons 72-73. HPV-DNA was detected in 48.97% of the cases the majority of which [64.6%] were of type 16. Significant correlation was found between p53 mutation and the pathological stage as well as p53 overexpression and tumor grade. Our results demonstrate that the mutational spectrum in BBC is different from that of bladder cancer in Western countries in many aspects and suggest an etiological role of HPV in this type of neoplasm. However, both HPV infection and p53 gene abnormalities may contribute to Bilharzial bladder carcinogenesis in an independent way.

Entities:  

Mesh:

Year:  2003        PMID: 14670539     DOI: 10.1016/s1078-1439(03)00014-0

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  17 in total

Review 1.  Vaccination against human papilloma virus (HPV): epidemiological evidence of HPV in non-genital cancers.

Authors:  Ioannis N Mammas; George Sourvinos; Apostolos Zaravinos; Demetrios A Spandidos
Journal:  Pathol Oncol Res       Date:  2010-07-18       Impact factor: 3.201

2.  Diagnostic value of fibronectin and mutant p53 in the urine of patients with bladder cancer: impact on clinicopathological features and disease recurrence.

Authors:  Sanaa Eissa; Samir F Zohny; Abdel-Rahman N Zekri; Tarek Mostafa El-Zayat; Amany M Maher
Journal:  Med Oncol       Date:  2009-12-11       Impact factor: 3.064

3.  Assessment of the Proliferative Marker Ki-67 and p53 Protein Expression in HBV- and HCV-related Hepatocellular Carcinoma Cases in Egypt.

Authors:  Waleed S Mohamed; Masoud M Omar; Tarek M Khayri; Ibrahim M Fakhr
Journal:  Int J Health Sci (Qassim)       Date:  2008-01

4.  Human papillomavirus infection and bladder cancer risk: a meta-analysis.

Authors:  Ni Li; Lin Yang; Yawei Zhang; Ping Zhao; Tongzhang Zheng; Min Dai
Journal:  J Infect Dis       Date:  2011-07-15       Impact factor: 5.226

5.  Low prevalence of HPV detection and genotyping in non-muscle invasive bladder cancer using single-step PCR followed by reverse line blot.

Authors:  Renate Pichler; Wegene Borena; Georg Schäfer; Claudia Manzl; Zoran Culig; Sebastian List; Sabrina Neururer; Dorothee Von Laer; Isabel Heidegger; Helmut Klocker; Wolfgang Horninger; Hannes Steiner; Andrea Brunner
Journal:  World J Urol       Date:  2015-03-19       Impact factor: 4.226

6.  Role of human papillomavirus in the development of urothelial carcinoma.

Authors:  Dilek Yavuzer; Nimet Karadayi; Taflan Salepci; Huseyin Baloglu; Ahmet Bilici; Dilek Sakirahmet
Journal:  Med Oncol       Date:  2010-04-29       Impact factor: 3.064

7.  Implications of transcriptional factor, OCT-4, in human bladder malignancy and tumor recurrence.

Authors:  Peng Huang; Jie Chen; Lei Wang; Yanqun Na; Haruki Kaku; Hideo Ueki; Katsumi Sasaki; Ken Yamaguchi; Kai Zhang; Takashi Saika; Yasutomo Nasu; Masami Watanabe; Hiromi Kumon
Journal:  Med Oncol       Date:  2011-05-01       Impact factor: 3.064

8.  Role of human papillomavirus types 16, 18, and 52 in recurrent cystitis and urinary bladder cancer among Egyptian patients.

Authors:  Hala Badawi; Hanem Ahmed; Ahmed Ismail; Manal Diab; Magd Moubarak; Afkar Badawy; Mohamed Saber
Journal:  Medscape J Med       Date:  2008-10-08

9.  Decreased expression of microRNA-31 associates with aggressive tumor progression and poor prognosis in patients with bladder cancer.

Authors:  S Wang; Q Li; K Wang; Y Dai; J Yang; S Xue; F Han; Q Zhang; J Liu; W Wu
Journal:  Clin Transl Oncol       Date:  2013-02-14       Impact factor: 3.405

Review 10.  Controversies and challenges in research on urogenital schistosomiasis-associated bladder cancer.

Authors:  Jared Honeycutt; Olfat Hammam; Chi-Ling Fu; Michael H Hsieh
Journal:  Trends Parasitol       Date:  2014-06-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.